基因组生物标志物预测对ATR抑制和放射治疗联合反应的反应
Benjamin R Schrank1, Lauren E Colbert1
1Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
概括
一项新的研究表明,激酶抑制剂RP-3500与辐射合作,治疗缺乏ATM的瘤. 这种方法需要针对基因型的策略,因为它没有影响其他瘤类型.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 辐射疗法 辐射疗法
背景情况:
- 检查点激酶抑制剂长期以来一直被认为是化学辐射敏感的理论,但仍然在很大程度上未经调查.
- 准DNA损伤反应通路是癌症治疗的关键策略.
研究的目的:
- 为了研究一种新型的阿塔克西亚 (telangiectasia) 和与Rad3相关的 (ATR) 激酶抑制剂RP-3500的疗效,与放射治疗结合使用.
- 确定RP-3500在辐射敏感化中的基因型特异性影响.
主要方法:
- 在体内研究使用具有不同遗传背景的瘤模型 (Atm-/-,野生类型,Brca-1-缺乏).
- 与放射治疗一起使用ATR激酶抑制剂RP-3500.
- 评估瘤控制和辐射敏感化效应.
主要成果:
- ATR抑制剂RP-3500与辐射具有协同效应,从而在体内显著控制了Atm-/-瘤.
- 在野生型或Brca-1缺乏的瘤中,RP-3500没有表现出辐射敏感作用.
- 这些发现强调了基因背景在决定治疗反应中的重要性.
结论:
- 新型ATR抑制剂RP-3500显示出作为放射敏感剂的前景,特别是在ATM缺乏的瘤中.
- 基因型量身定制的方法对于优化RP-3500和类似的向治疗的临床应用至关重要.
- 需要进一步的研究来探索ATR抑制剂在联合癌症治疗中的全部潜力.
更多相关视频
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
16.5K
05:39Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
Published on: April 5, 2024
768
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K